companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

BUTYN L & L

SCOTLAND-Canada

Company Name:
Corporate Name:
BUTYN L & L
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: RR 1,SCOTLAND,ON,Canada 
ZIP Code:
Postal Code:
N0E 
Telephone Number: 5194463130 
Fax Number: 5193675204 
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
0 
USA SIC Description:
Home Improvements 
Number of Employees:
 
Sales Amount:
$500,000 to $1 million 
Credit History:
Credit Report:
Good 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
CHARY PRODUCE
CANADIAN LEGION BRANCH
CANADA POST
Next company profile:
BRIGHT SKY
BRANT FLOUR MILLS LTD
BRANT FLOUR MILLS LTD










Company News:
  • Frontline treatment of follicular lymphoma: What will it take to change . . .
    Follicular lymphoma is the most common subtype of indolent lymphoma Despite multiple trials over the past decade showing improved progression-free survival with new first-line therapeutic strategies -such as anti-CD20 maintenance therapy and new glycoengineered anti-CD20 antibodies- no standardized approach has been widely adopted in routine clinical practice Several factors may explain this
  • Current and future therapies for follicular lymphoma
    Follicular lymphoma (FL) is an indolent, germinal center B cell–derived lymphoid neoplasm, for which recent advances in treatment have substantially improved patient survival However, FL remains an incurable and heterogeneous disease, with groups of patients experiencing early disease progression, histologic transformation, or a high risk of treatment-related toxicity Additionally, FL is a
  • Follicular Lymphoma Treatment: Whats the Latest?
    Follicular lymphoma is a slow-growing form of non-Hodgkin lymphoma (NHL) that arises in white blood cells called B lymphocytes It’s named for the clumps of abnormal B cells, called follicles, that develop in patients’ lymph nodes It accounts for 20-30% of all cases of NHL Although follicular lymphoma currently isn’t curable, patients can live with it for many years, making it more of
  • Follicular Lymphoma: A New First-Line Therapy?
    Diffuse large B-cell lymphoma and follicular lymphoma are two of the most common subtypes, and mantle cell lymphoma (MCL) is a particularly aggressive subtype As scientific advances in diagnosis and treatment lead to more and better treatment options, the prognosis for people with NHL continues to improve
  • Advances in Personalized Treatment and Prognostic Factors of Follicular . . .
    Follicular lymphoma is the most prevalent form of indolent B-cell lymphoma, characterized by gradual disease progression and potential survival over several decades Although the overall prognosis is typically favorable, some patients remain at risk for disease progression or transformation into a more aggressive variant Recent advancements in the treatment of relapsed or refractory
  • Follicular Lymphoma: Recent and Emerging Therapies, Treatment . . .
    Follicular lymphoma (FL) is a heterogeneous disease with varying prognosis owing to differences in clinical, laboratory, and disease parameters Although generally considered incurable, prognosis for early‐ and advanced‐stage disease has improved because of therapeutic advances, several of which have resulted from elucidation of the biologic and molecular basis of the disease The choice
  • The Future of Follicular Lymphoma Management . . . - ScienceDirect
    Progress in the therapy of follicular lymphoma (FL), the most common indolent lymphoma subtype, has been achieved in recent years with significant improvement in median overall survival Most patients diagnosed with FL will now die from other causes Multiple novel immunotherapy and other targeted therapies are now approved for relapsed and refractory disease However, early progression and
  • Follicular Lymphoma Updates | Follicular Lymphoma Foundation
    Explore recent advancements in follicular lymphoma research, highlighting new clinical and translational investigative pathways
  • Targeted Therapy Combinations Could Represent Next Wave of Treatments . . .
    Geoffrey Shouse, DO, PhD, discusses the benefits of utilizing targeted therapy approaches in the treatment of patients with follicular lymphoma
  • The Future of Follicular Lymphoma Management: Strategies on the Horizon
    Progress in the therapy of follicular lymphoma (FL), the most common indolent lymphoma subtype, has been achieved in recent years with significant improvement in median overall survival Most patients diagnosed with FL will now die from other causes




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer